Profound underestimation of glucose uptake by [18F]2-deoxy-2- fluoroglucose in reperfused rat heart muscle

Circulation

Volumn 97, Issue 24, 1998, Pages 2454-2462

  Doenst, Torsten ^a,b   Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Enzymes; Fatty acids; Glucose; Ischemia; Nuclear medicine; Radioisotopes

Indexed keywords

CITRATE SYNTHASE; FLUORODEOXYGLUCOSE F 18; HEXOKINASE; OLEIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CYTOSOL; ENZYME ACTIVITY; ENZYME KINETICS; GLUCOSE TRANSPORT; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032560631     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.24.2454     Document Type: Article

References (14)

1. Maddahi J, Blitz A, Phelps M, Laks H. The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy. Adv Card Surg. 1996;7:163-188.
2. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897-916.
3. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Scheibert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
4. Stone CK, Holden JE, Stanley W, Perlman SB. Effect of nicotinic acid on exogenous myocardial glucose utilization. J Nucl Med. 1995;36:996-1002.
5. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Scheibert HR, Nienaber CA, Phelps ME. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989;30:359-366.
6. Knuuti MJ, Nuutila P, Ruotsolainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Voipio-Pulkki LM. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med. 1993;34: 2068-2075.
7. 14C] deoxyglucose as markers of glycolysis in reperfused myocardium. Circ Res. 1992;71:689-700.
8. Russell RR, Mrus JM, Mommesin JI, Taegtmeyer H. Compartmentation of hexokinase in rat heart: a critical factor for tracer kinetic analysis of myocardial glucose metabolism. J Clin Invest. 1992;90:1972-1977.
9. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 1995;91:2435-2444.
10. Ng CK, Holden JE, DeGrado TR, Raffel DM, Kornguth ML, Galley SJ. Sensitivity of myocardial fluorodeoxyglucose lumped constant to glucose and insulin. Am J Physiol. 1991;260:H593-H603.
11. Crane P, Pardridge W, Braun L, Oldendorf W. Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain. J Neurochem. 1983;40:160-167.
12. Grossbard L, Schimke RT. Multiple hexokinases of rat tissues: purification and comparison of soluble forms. J Biol Chem. 1966;241:3546-3560.
13. Nakai H, Matsuda H, Takara E, Diksic M, Meyer E, Yamamoto YL. Simultaneous in vivo measurement of lumped constants in experimental cerebral ischemia using F-18 FDG. Stroke. 1987;18:158-167.
14. 14C]deoxyglucose technique. J Cereb Blood Flow Metab. 1992;12:70-77.